Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Certain bonds and fund structures minimize tax impact, making them attractive for retirees seeking reliable after-tax income.
22,683 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Reddit reveals a bold plan to reach one billion users, signaling a major shift from niche message boards to a mainstr...
Curious about Cerebras stock and its three-year outlook? This guide breaks down growth drivers, risks, and three scen...
DeepMind’s 2010 seed and Google’s 2014 buyout sparked debate about exit timing in AI. This report weighs whether the ...
When a tech giant like Meta Platforms hints at neocloud moves, investors crave clarity. This article breaks down what...
PetSmart confirms the closure of its lone San Francisco location as online shopping reshapes the pet retail landscape...
AI advances hinge on memory tech. As the world’s top HBM maker becomes accessible to U.S. investors, learn how this s...
What if SpaceX and xAI merged to run data centers in orbit? This article breaks down how orbital compute could work, ...
Amazon enters the back half of 2026 with sustained AWS growth, a scaling silicon stack, and a resilient Prime-driven ...
November 2025 marks a new milestone as the Bitcoin Lightning Network surpasses $1B in monthly volume, signaling a shi...
Tech giants push AI-led gains as the Nasdaq plays catch-up, with policy updates and earnings previews guiding a cauti...
Block announces a sweeping AI-driven layoff, cutting roughly 4,000 jobs and shrinking headcount to under 6,000. The m...